-
-
-
-
-
-
-
Rosetta Genomics Urges Shareholders to Vote FOR the Proposed Merger with Genoptix
-
-
-
-
-
-
-
Rosetta Genomics Announces Results from Extraordinary General Meeting of Shareholders to Vote on Proposed Merger with Genoptix
-
-
-
-
-
-
-
Rosetta Genomics Enters Research Collaboration using microRNA Biomarkers to Predict Response to Leading Immuno-Oncology Drug Nivolumab in Lung Cancer Patients
-
-
-
-
-
-
-
Rosetta Genomics (ROSG) Enters Distribution Agreement with Rhenium for RosettaGX Reveal in Israel
-
-
-
-
-
-
-
Rosetta Genomics (ROSG) Enters into Services Agreement with Unnamed Global Pharmaceutical Company
-
-
-
-
-
-
-
Rosetta Genomics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
-
-
-
-
-
-
Rosetta Genomics Reports 2016 First Quarter Financial Results
-
1,157,730 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

